Other Royalties. In addition, Novartis shall pay to Juno [***] percent ([***]%) of the royalties that would be due under the royalty basis described in the attached Exhibit 3.02(b), as if paid by Novartis to Penn for Net Sales of Licensed Products pursuant to the Penn-Novartis Collaboration (Including as such basis may be applied to Licensed Services as contemplated under this Agreement in the definition of Net Sales provided herein as well as Licensed Products, whether murine, human or other forms of CART19) as of the Effective Date. For example, and not by way of limitation, Novartis may owe Juno [***] percent ([***]%) of the [***] percent ([***]%) royalty expressed on the top left corner of the first Table expressed in Exhibit 3.02(b) (i.e., the top row of Table A in Exhibit 3.02(b) under the heading “I. Royalty Rate Applicable to any Initial CED-19 Product”), but applying the definition of Net Sales provided hereunder. Juno acknowledges and agrees that “royalty payments” as used in the foregoing sentence does not include [***]. Notwithstanding anything to the contrary, if Novartis and Penn agree at any time after the Effective Date to amend any aspect of the Penn-Novartis Collaboration that alters the terms for payment of royalties under the Penn-Novartis Collaboration, and such alteration would reduce the royalty payment owed to Penn, then such amended terms shall not in any manner reduce the royalty payment due to Juno under this Agreement determined as of the Effective Date; provided, however, if Novartis and Penn amend the Penn-Novartis Collaboration or otherwise enter into an agreement on or after the Effective Date that increases the royalty payment payable by Novartis to Penn pursuant to the Penn-Novartis Collaboration, then Exhibit 3.02(b) shall be deemed amended to reflect any such increase, and the royalty payment due to Juno shall be increased to correspond to the amended Exhibit 3.02(b). [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Other Royalties. The parties shall negotiate in good faith the financial terms pertaining to royalty payments for sales of Royalty-Bearing Products based on compounds resulting from the screening described in Subsection 4.1.6 or for uses of a Royalty-Bearing Product within the Field for purposes other than as a human therapeutic or prophylactic for [*****], which terms shall be set forth in a separate agreement.
Other Royalties. Producer agrees to pay to Composer, and Composer agrees to accept, the following royalties with respect to the Score:
Other Royalties. 7.1.5 Royalty Term. ****************************************** ******************************************************************************** ******************************************************************************** ******************************************************************************** 25 -21- ******************************************************************************** ******************************************************************************** ***********************************
Other Royalties. If Publisher should exercise any of the rights it has been granted within this Agreement and no corresponding royalty rate is specified elsewhere in this Agreement, the royalty rate will be negotiated in good faith between Publisher and Author. Specifically, Author recognizes that for adaptations published by Publisher at a reduced suggested retail price, the royalty will be significantly reduced to reflect the limited margins on these products.
Other Royalties. In the event HVT distributes products or services utilizing Licensed Technology which products or services are not contemplated under Service Royalties, Software Royalties or Key Royalties ("Other Products and Services"), then the Parties will negotiate in good faith appropriate royalties for such Other Products and Services using the royalties in this Article 7 as guidelines ("Other Royalties"). If Other Royalties cannot be amicably reached, such Other Royalties will be determined through binding arbitration; provided, however, that during such arbitration HVT may distribute such Other Products and Services and will pay a interim royalty to iPIX in an amount equal to *
Other Royalties. In the case of Non-Monoclonal Antibody Products and on a country by country basis, in the event that royalties are to be paid by RBS to a party who is not an Affiliate of LKS, to make, use or sell Product for which royalties are also due to LKS hereunder (such royalties to such party are hereinafter "Other Royalties") and such Other Royalties are in excess of three percent (3%) of Net Sales of Product, then the royalties to be paid to LKS by RBS pursuant to this Agreement shall be reduced by onehalf of the amount of such Other Royalties in excess of three percent (3%) of Net Sales of Product, but at no time will LKS receive either less than a 4% royally on Net Sales for such Products where there is Patent Protection or less than a 2.5% royally on Net Sales for such Products where there is No Patent Protection.
Other Royalties. Save and except as disclosed in the Disclosed Creditors, all royalties due and payable by the Group or any member of the Group to landowners and other non-governmental entities have been fully paid and also reasonable provision has been made for all such royalties in respect of any production which has occurred and on which the royalties are calculated but not yet due and payable.
Other Royalties. Company does not agree to pay to DJ, and DJ agrees to accept there will be no royalty paid from music distribution.
Other Royalties. If, in conjunction with the generation of electricity, Lessee treats or processes or causes to be treated or processed, any geothermal resources for the extraction or manufacture therefrom of byproducts, and sells any of said byproducts, Lessee shall pay to Lessor, within the time frame described in paragraph (c) above, a royalty of *** percent (***%) of the proceeds from the sale by Lessee of said byproducts; less
